tiprankstipranks
Dr. Reddy's Laboratories Ltd (DE:RDDA)
FRANKFURT:RDDA
Germany Market
RDDA
Dr Reddy's Laboratories
RESEARCH TOOLSreports

Dr Reddy's Laboratories (RDDA) Financial Statements

4 Followers

Dr Reddy's Laboratories Financial Overview

Dr Reddy's Laboratories's market cap is currently €8.87B. The company's EPS TTM is €39.83; its P/E ratio is 29.66; Dr Reddy's Laboratories is scheduled to report earnings on July 22, 2026, and the estimated EPS forecast is €0.08. See an overview of income statement, balance sheet, and cash flow financials.
Mar 26Mar 25Mar 24Mar 23Mar 22
Income Statement
Total Revenue₹ 353.47B₹ 325.54B₹ 279.16B₹ 245.88B₹ 214.39B
Gross Profit₹ 186.52B₹ 190.43B₹ 163.61B₹ 139.34B₹ 113.84B
Operating Income₹ 48.87B₹ 71.84B₹ 67.73B₹ 57.14B₹ 29.48B
EBITDA₹ 83.29B₹ 96.67B₹ 88.42B₹ 74.43B₹ 45.08B
Net Income₹ 45.09B₹ 56.54B₹ 55.68B₹ 45.07B₹ 23.57B
Balance Sheet
Cash & Short-Term Investments₹ 86.08B₹ 57.91B₹ 81.47B₹ 61.80B₹ 44.37B
Total Assets₹ 567.88B₹ 492.99B₹ 387.52B₹ 321.85B₹ 292.83B
Total Debt₹ 75.81B₹ 46.77B₹ 20.02B₹ 13.47B₹ 33.84B
Net Debt₹ 60.75B₹ 32.11B₹ 12.91B₹ 7.69B₹ 18.99B
Total Liabilities₹ 194.95B₹ 155.82B₹ 106.97B₹ 90.86B₹ 102.30B
Stockholders' Equity₹ 369.60B₹ 333.39B₹ 280.55B₹ 230.99B₹ 190.53B
Cash Flow
Free Cash Flow₹ 32.10B₹ 12.03B₹ 18.00B₹ 40.01B₹ 9.06B
Operating Cash Flow₹ 56.65B₹ 46.43B₹ 45.43B₹ 58.88B₹ 28.11B
Investing Cash Flow₹ -70.53B₹ -58.08B₹ -40.28B₹ -41.37B₹ -26.39B
Financing Cash Flow₹ 13.40B₹ 18.91B₹ -3.76B₹ -26.86B₹ -2.42B
Currency in INR

Dr Reddy's Laboratories Earnings and Revenue History

Income Statement >

Dr Reddy's Laboratories Debt to Assets

Balance Sheet >

Dr Reddy's Laboratories Cash Flow

Cash Flow >

Dr Reddy's Laboratories Forecast EPS vs Actual EPS

Earnings >